Should medical data be treated differently from other personal data, and what impact will Europe’s new GDPR rules have on medical research and health tech companies? Darren Dodd puts these questions to the FT’s Sarah Neville, Tina Woods of Collider Health and data protection and privacy expert Kristof van Quathem.

Contribute to our listener survey and enter our prize draw here.

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on News in Focus when a new story is published

Copyright The Financial Times Limited 2020. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast